Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0000899243-23-000973 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-05 | 2023-01-03 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $37.46 | -53.7K | 96.0K | -36% | -$2.01M |
| DM | 2023-01-05 | 2023-01-03 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.9558 | +53.7K | 105.1K | +105% | +$51.4K |
| DM | 2023-01-05 | 2023-01-03 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.00 | -53.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | S | D | 1,900 | $39.07 | 96,562 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.82 to $39.75, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2023-01-03 | S | D | 13,704 | $37.99 | 98,462 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.66 to $38.48, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2023-01-03 | S | D | 37,525 | $37.14 | 112,166 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.66 to $37.65, inclusive. The Reporting Person undertakes to provide Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2023-01-03 | M | A | 40,297 | $0.67 | 149,691 | D | — | — | |
| 5 | Common | Common Stock | 2023-01-03 | M | A | 4,326 | $4.22 | 109,394 | D | — | — | |
| 6 | Common | Common Stock | 2023-01-03 | M | A | 9,106 | $0.67 | 105,068 | D | — | — | |
| 7 | Common | Common Stock | 2023-01-03 | S | D | 600 | $39.94 | 95,962 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-01-03 | M | D | 40,297 | $0.00 | 150,905 | D | $0.67 · — to 2028-05-08 | 40,297 Common Stock | (F6) The shares subject to this stock option vested 25% on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-01-03 | M | D | 9,106 | $0.00 | 0 | D | $0.67 · — to 2028-05-08 | 9,106 Common Stock | (F5) The option award vested upon the achievement of a closing price hurdle following BEAM's initial public offering (which closing price hurdle has been achieved) in three equal installments on December 21, 2021, June 30, 2022 and December 31, 2022. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-01-03 | M | D | 4,326 | $0.00 | 0 | D | $4.22 · — to 2029-02-13 | 4,326 Common Stock | (F5) The option award vested upon the achievement of a closing price hurdle following BEAM's initial public offering (which closing price hurdle has been achieved) in three equal installments on December 21, 2021, June 30, 2022 and December 31, 2022. |